Literature DB >> 23571733

Statins and lipid metabolism: an update.

Stefania Lamon-Fava1.   

Abstract

PURPOSE OF REVIEW: The reduction in cardiovascular disease risk by statins is well established. This risk reduction has mostly been attributed to decreases in plasma LDL cholesterol and other pleiotropic effects of statins. Emerging evidence indicates that statins exert multiple effects on lipoprotein metabolism, including chylomicrons and HDLs. RECENT
FINDINGS: Kinetic and in-vitro studies have documented that the effects of statins on the metabolism of different lipoproteins are for the most part the direct consequence of cholesterol biosynthesis inhibition and the subsequent change in transcription factors and cell signaling, regulating different aspects of lipoprotein metabolism. Differences in pharmacokinetics and pharmacodynamics among statins lead to diverse biological outcomes.
SUMMARY: The current review summarizes recent experimental evidence highlighting the different effects of statins on cellular pathways regulating gene expression. Understanding the basic mechanisms by which different statins regulate lipoprotein metabolism will lead to improved strategies for the prevention and treatment of specific lipoprotein disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23571733     DOI: 10.1097/MOL.0b013e3283613b8b

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  8 in total

1.  Engineering Saccharomyces cerevisiae for production of simvastatin.

Authors:  Carly M Bond; Yi Tang
Journal:  Metab Eng       Date:  2018-09-10       Impact factor: 9.783

2.  Single-step fermentative production of the cholesterol-lowering drug pravastatin via reprogramming of Penicillium chrysogenum.

Authors:  Kirsty J McLean; Marcus Hans; Ben Meijrink; Wibo B van Scheppingen; Aad Vollebregt; Kang Lan Tee; Jan-Metske van der Laan; David Leys; Andrew W Munro; Marco A van den Berg
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

3.  Synthesis and evaluation of novel amide amino-β-lactam derivatives as cholesterol absorption inhibitors.

Authors:  Tonko Dražić; Vinay Sachdev; Christina Leopold; Jay V Patankar; Martina Malnar; Silva Hećimović; Sanja Levak-Frank; Ivan Habuš; Dagmar Kratky
Journal:  Bioorg Med Chem       Date:  2015-03-31       Impact factor: 3.641

4.  ABCC6- a new player in cellular cholesterol and lipoprotein metabolism?

Authors:  Patricia Kuzaj; Joachim Kuhn; Mareike Dabisch-Ruthe; Isabel Faust; Christian Götting; Cornelius Knabbe; Doris Hendig
Journal:  Lipids Health Dis       Date:  2014-07-27       Impact factor: 3.876

5.  Atorvastatin Inhibits the HIF1α-PPAR Axis, Which Is Essential for Maintaining the Function of Human Induced Pluripotent Stem Cells.

Authors:  Yoshiki Nakashima; Chika Miyagi-Shiohira; Hirofumi Noguchi; Takeshi Omasa
Journal:  Mol Ther       Date:  2018-06-19       Impact factor: 11.454

Review 6.  Molecular Pathways Underlying Cholesterol Homeostasis.

Authors:  Milessa Silva Afonso; Roberta Marcondes Machado; Maria Silvia Lavrador; Eder Carlos Rocha Quintao; Kathryn J Moore; Ana Maria Lottenberg
Journal:  Nutrients       Date:  2018-06-13       Impact factor: 5.717

Review 7.  Physiology and Pathophysiology of Steroid Biosynthesis, Transport and Metabolism in the Human Placenta.

Authors:  Waranya Chatuphonprasert; Kanokwan Jarukamjorn; Isabella Ellinger
Journal:  Front Pharmacol       Date:  2018-09-12       Impact factor: 5.810

8.  Novel amino-β-lactam derivatives as potent cholesterol absorption inhibitors.

Authors:  Tonko Dražić; Krešimir Molčanov; Vinay Sachdev; Martina Malnar; Silva Hećimović; Jay V Patankar; Sascha Obrowsky; Sanja Levak-Frank; Ivan Habuš; Dagmar Kratky
Journal:  Eur J Med Chem       Date:  2014-10-07       Impact factor: 6.514

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.